Predictive Oncology Engages LifeSci Advisors as Strategic Investor Relations Partner
March 14, 2023 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., March 14, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Predictive Oncology Issues Letter to Shareholders
March 09, 2023 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., March 09, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities to...
Predictive Oncology and Cvergenx announce partnership to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using artificial intelligence
February 23, 2023 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) and Cvergenx, Inc. today announced an agreement to form a strategic partnership that has the potential to...
Predictive Oncology launches ACE program to partner with academic and research institutions to advance their drug discovery initiatives
February 21, 2023 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) today announced the launch of ACE (Accelerating Compound Exploration), a program to advance the oncology drug...
Predictive Oncology Appoints Pamela Bush, Ph.D., MBA, as Chief Business Officer
February 03, 2023 08:31 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) is pleased to announce the appointment of Pamela Bush, Ph.D., MBA, as Chief Business Officer. Dr. Bush will...
Pioneer of Computational Biology Joins the Scientific Advisory Board of Predictive Oncology
January 12, 2023 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) today announced the appointment of Robert F. Murphy, Ph.D., to the company’s Scientific Advisory Board where...
Distinguished Innovator in Genomics Joins the Scientific Advisory Board of Predictive Oncology
December 13, 2022 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) today announced the appointment of Marc Malandro, Ph.D., to the company’s Scientific Advisory Board where he...
Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of Directors
December 05, 2022 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) is pleased to announce the appointment of Matthew J. Hawryluk, Ph.D., (www.predictive-oncology.com) to its...
Predictive Oncology Reports Third Quarter Financial Results
November 10, 2022 17:15 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) today announced the financial results for its third quarter ended September 30, 2022, which continue to...
David S. Smith appointed to the Board of Directors of Predictive Oncology
October 25, 2022 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) is pleased to announce the appointment of David S. Smith, JD, to the company’s Board of Directors. Mr. Smith is a...